2024;14(1):5078.[DOI] 111
Mc Carthy DJ, Malhotra M, OMahony AM, Cryan JF, ODriscoll CM
Compound Overview Class of Compound Peptide Mechanism of Action Melanotan I is an agonist of melanocortin receptors 1, 3, 4, and 5, binding primarily to melanocortin receptor 1 to trigger melanin production
Mild, transient fluid retention/edema and joint or muscle pain, each reported more often on MK-677 than placebo in the same trial, linked to elevated GH and IGF-1
Peptide therapy can stimulate the release of growth hormone, which promotes faster healingand enhanced muscle tissue growth
BPC-157 addresses the inflammatory and soft tissue components rather than the structural displacement itself